期刊文献+

Characterization and allergic role of IL-33-induced neutrophil polarization 被引量:9

原文传递
导出
摘要 Neutrophils are involved in the pathogenesis of allergy.However,the contribution of the different functionally polarized neutrophils in allergy needs to be clarified.We sought to define the characteristics of interleukin(IL)-33-induced neutrophils and the involvement of this subset of polarized neutrophils in allergic pathogenesis.Freshly isolated neutrophils were treated with different cytokines and the cytokine expression levels were detected by realtime PCR.The gene expression profile of IL-33-induced neutrophils was determined by microarray assay.Adoptive transfer assay was used to investigate the function of IL-33-induced neutrophils in an ovalbumin(OVA)-induced allergic asthma model.IL-33-treated neutrophils selectively produced IL-4,IL-5,IL-9 and IL-13(referred as to N(IL-33)cells)and displayed a distinctive gene expression profile in sharp contrast to resting and lipopolysaccharide(LPS)-treated neutrophils.IL-33-induced neutrophils expressed high Levels of IL-1R2 on cell surface,whereas resting and LPS-treated neutrophils did not,indicating IL-1R2 might be used as a biomarker for N(IL-33)cells.Importantly,N(IL-33)neutrophils exist in the lungs of OVA-induced allergic asthma mice.Adoptive transfer of N(IL-33)neutrophils significantly promotes the severity of the lung pathogenesis in this model.IL-33 induces neutrophil polarization through c-Jun N-terminal kinase-and nuclear factor-κB-dependent pathways.A previously unappreciated neutrophil polarization driven by IL-33 with unique cell surface markers and cytokine/chemokineproducing gene profile was defined.The newly identified N(IL-33)subpopulation may have significant contribution to IL-33-related pathogenesis.
出处 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2018年第8期782-793,共12页 中国免疫学杂志(英文版)
基金 supported by grants from the National Natural Science Foundation of China for General and Key Programs(81530049 and 81130055 to YZ) Knowledge Innovation Program of Chinese Academy of Sciences(XDA04020202-19 to YZ) the CAS/SAFEA International Partnership Program for Creative Research Teams(to YZ) Beijing Municipal Hospital Authority‘Yangfan Program’(ZYLX201408 to XZ).
  • 相关文献

参考文献3

二级参考文献152

  • 1Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation 2008; 117: 2131-2141.
  • 2Colvin-Adams M, Agnihotri A. Cardiac allograft vasculopathy: current knowledge and future direction. Clin Transplant2011; 25: 175-184.
  • 3Rahmani M, Cruz RP, Granville D J, McManus BM. AIIograft vasculopathy versus atherosclerosis. Circ Res 2006; 99: 801-815.
  • 4Valantine HA. Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma". Transplanta- tion 2003; 76: 891-899.
  • 5Behrendt D, Ganz P, Fang JC. Cardiac allograft vasculopathy. Curr Opin Cardio12000; 15: 422-429.
  • 6Blakely ML, Van der Werf W J, Berndt MC, Dalmasso AP, Bach FH & Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059-1066.
  • 7Zhang XP, Kelemen SE, Eisen HJ. Quantitative assessment of cell adhesion molecule gene expression in endomyocardial biopsy specimens from cardiac transplant recipients using competitive polymerase chain reaction. Transplantation 2000; 70: 505-513.
  • 8Mancini MC, Evans JT. Role of platelet-derived growth factor in allograft vasculopathy. Ann Surg 2000; 231: 682-688.
  • 9van Loosdregt J, van Oosterhout MF, BrugginkAH, van Wichen DF, van Kuik J, de Koning E et al. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. Circulation 2006; 114: 1599-1607.
  • 10Mantovani A, Cassatella MA, Costantini C, Jailton S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Imrnuno12011:11: 519-531.

共引文献14

同被引文献32

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部